Core Insights - Rapid Micro Biosystems, Inc. is an innovative life sciences technology company focused on providing automation solutions for the efficient manufacturing and safe release of healthcare products [3] Company Overview - The company specializes in automation solutions for microbial quality control (MQC) testing workflows in pharmaceutical manufacturing, enhancing efficiency and compliance [3] - Its flagship product, the Growth Direct system, modernizes traditional MQC testing, delivering faster results and greater accuracy [3] - Rapid Micro Biosystems is headquartered in Lexington, Massachusetts, with manufacturing in Lowell, Massachusetts, and additional locations in Switzerland, Germany, and the Netherlands [3] Upcoming Events - The company will present at the TD Cowen 45 Annual Health Care Conference on March 4, 2025, at 11:10 a.m. ET in Boston, Massachusetts [4] - A virtual question-and-answer session will take place at the KeyBanc Capital Markets Healthcare Forum on March 19, 2025, at 11:15 a.m. ET [4]
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences